Go to main content

Types of Collaboration

GC Biopharma continues to
Strengthen and diversify
Partner relations.

Photo that shows partnership

In-Licensing

In addition to maximizing the efficiency of its own research organization, GC Biopharma has also been generating significant R&D synergy and open innovation through active exchange and collaboration with academia, innovative biotechnology startups, and leading global Biopharmaceutical companies. GC Biopharma’s partners in and outside Korea continue to give the company an edge over its technological competition on the global biotechnology market and enable it to reinforce its R&D pipeline.

GC Biopharma Looks for Partners Interested in Jointly Expanding R&D Pipelines Together

GC Biopharma continues to seek partnerships with companies with extensive experience in researching and developing biological products, including vaccines, plasma derivatives, and recombinant proteins. We aim to partner with companies that possess the necessary infrastructure for supporting biological product research and those committed to developing products for in-licensing.
Additionally, we aim to work alongside companies with experience and capabilities in successfully commercializing in-licensed products.

Out-Licensing

GC Biopharma has extensive experience with the R&D of biological agents, such as vaccines, plasma derivatives, and recombinant proteins. The company employs professional R&D resources and possesses the requisite capabilities for licensing, clinical trials, and fostering business relations related to such products. Throughout licensing, GC Biopharma allows its partners to access its R&D and clinical trial divisions' expertise, as well as its competitive product offerings. Under its mid-to-long-term global growth strategy, the company actively seeks partnership opportunities across the products and technologies it researches, develops, or has already released into the market.

이메일집단수집거부

GC녹십자는 이메일 수집을 거부합니다

본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나
그 밖의 기술적 장치를 이용하여 무단으로 이메일 주소를 수집하는 행위를 거부하며,
이를 위반시 정보통신망 이용촉진 및 정보보호 등에 관한 법률에 의해 형사처벌됨을
유념하시기 바랍니다

게시일: 2003년 9월 1일